Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine.
about
Fatigue Management in Multiple SclerosisThe Role of fMRI to Assess Plasticity of the Motor System in MSPresent and future of fMRI in multiple sclerosis.Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.Functional brain reorganization in multiple sclerosis: evidence from fMRI studies.Functional MRI in multiple sclerosis.Functional MRI in investigating cognitive impairment in multiple sclerosis.Neuroplasticity and functional recovery in multiple sclerosis.Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor functionOral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.Spring cleaning: time to rethink imaging research lines in MS?Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue.Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis.Voltage-dependent potassium currents during fast spikes of rat cerebellar Purkinje neurons: inhibition by BDS-I toxin.Prolonged-Release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: A Pilot, Double-Blind, Randomized, Placebo-Controlled Study.Application of fMRI to Multiple Sclerosis and Other White Matter Disorders
P2860
Q26752946-11841E6E-264F-4584-AF60-442B0B53B75AQ26863248-1DBFD232-B5CB-4083-84A0-11E684D12BDFQ30704369-89A2EC65-B506-44CB-9ECC-7BA560E1B290Q31032881-1462C10C-7D1C-4D7A-862A-58EC0AE27DECQ31037475-2372594D-70B8-4BDD-AE2B-FEA9D2AEF0E0Q31108869-12554F27-66D9-4A56-ABA9-80EE3EC4A777Q31125899-D438F2D7-1F6E-4848-A368-DEE9D5A778AEQ37164200-D139BB40-AA68-4D5E-884F-5BC6AB06CFC8Q37199824-E26D8332-7296-4369-B005-62FE604E98DEQ38730482-5A0069CD-2D95-4034-9C5A-A0DD92B5B78CQ38737202-5ECFCB58-9891-43B3-A7F0-8C8E8FC6EDE4Q44095984-D766B809-EFC1-465E-8328-3558405EE9D4Q44674662-17300C1A-C1BE-49B4-B738-2B5DAC000608Q46104228-D816361A-26D7-4E30-9A6D-468B1B907327Q46157361-B5FB95B4-00FF-4C39-9FBF-C753FC72531EQ48387602-DBD69945-EA4B-4BCC-B70B-FDD906661C7EQ52649561-CA1A02F7-F6EC-44CB-B191-73BE2FA848A9Q57911648-154E3F6C-7D66-41E2-944E-30BAA279839C
P2860
Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Enhanced brain motor activity ...... e dose of 3,4-diaminopyridine.
@en
Enhanced brain motor activity ...... e dose of 3,4-diaminopyridine.
@nl
type
label
Enhanced brain motor activity ...... e dose of 3,4-diaminopyridine.
@en
Enhanced brain motor activity ...... e dose of 3,4-diaminopyridine.
@nl
prefLabel
Enhanced brain motor activity ...... e dose of 3,4-diaminopyridine.
@en
Enhanced brain motor activity ...... e dose of 3,4-diaminopyridine.
@nl
P2093
P1433
P1476
Enhanced brain motor activity ...... e dose of 3,4-diaminopyridine.
@en
P2093
Inghilleri M
Pozzilli C
P304
P356
10.1212/01.WNL.0000129263.14219.A8
P407
P577
2004-06-01T00:00:00Z